עדכונים > מאמרים בשיתוף אונקוטסט

Next-Genaration Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib Sensitive ALK Rearrangement in a Patient with Metastatic Non-Small-Cell Lung Cancer

Next-Genaration Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib Sensitive ALK Rearrangement in a Patient with Metastatic Non-Small-Cell Lung Cancer

Peled et al, 2012 Journal of Thoracic Oncology

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645938/

Authors:

Nir Peled, MD, PhD, Gary Palmer, MD, Fred R. Hirsch, MD, PhD, Murry W. Wynes, PhD, Maya Ilouze, PhD, Marileila Varella-Garcia, PhD, Lior Soussan-Gutman, PhD, Geoff A. Otto, PhD, Philip J. Stephens, PhD, Jeffrey S. Ross, MD, Maureen T. Cronin, PhD, Doron Lipson, PhD, and Vincent A. Miller, MD